1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > 2015-2019 Global Influenza Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Strategies--Competitive Landscape, Supplier Shares, Country Volume and Sales Segment Forecasts

The report presents a detailed analysis of the Influenza diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Influenza definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Influenza tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 232 pages and 15 tables

The report presents a detailed analysis of the Influenza diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Influenza definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Influenza tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 232 pages and 15 tables

Table Of Contents

2015-2019 Global Influenza Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Strategies--Competitive Landscape, Supplier Shares, Country Volume and Sales Segment Forecasts
Global Influenza Diagnostics Market
Growth Opportuinites and Business Expansion Strategies

Table of Contents

I. Introduction
II. Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
0 Abbott AxSYM
0 Abbott IMx/IMx Select
0 Anagen AN2000/AuraFlex
0 Beckman Coulter Access
0 BioChem Pharma/SR1
0 BioMerieux/Vitek Vidas
0 Biotrol System 7000
0 Chiron ACS: Centaur
0 Chiron ACS: 180
0 JandJ Diagnostics/Amersham Amerlite
0 JandJ Diagnostics Vitros ECi
0 Olympus PK310
0 Roche Cobas Core
0 Roche Elecsys 1010/2010
0 Roche ES 22
0 Roche ES 33
0 Roche ES 300/300AL
0 Siemens ELISA Processor II/III
0 Siemens Immuno 1
0 Siemens/Opus/Plus/Magnum
0 Siemens Stratus
0 Tosoh AIA-1200/1200DX/NexIA/600
0 Wallac/Pharmacia Delfia
E. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
0 Polymerase Chain Reaction

- Robotics
- Temperature Cyclers
- PCR Variations
0 Immuno-PCR
0 QC-PCR
0 DAP-PCR
0 Ligase Chain Reaction
0 Branched DNA
0 Q-Beta Replicase
0 Nucleic-Acid Sequence-Based
0 Strand Displacement Activation
0 Self-Sustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
0 Overview
0 ELISA
0 Dot Immunobinding Assays
0 Capillary Immunoassays
0 Particle-Membrane Capture Immunoassays
0 Enzyme Amplification
c. Fluorescent Immunoassays
0 Fluorescence Polarization
0 Time-Resolved Pulse Fluorescence
d. Luminescence
0 Chemiluminescence
0 Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
III. France: Market Size, Growth and Major Suppliers' Sales
and Market Shares

IV. Germany: Market Size, Growth and Major Suppliers' Sales
and Market Shares

V. Italy: Market Size, Growth and Major Suppliers' Sales
and Market Shares
VI. Japan: Market Size, Growth and Major Suppliers' Sales
and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers' Sales
and Market Shares
VIII. UK: Market Size, Growth and Major Suppliers' Sales
and Market Shares
IX. USA: Market Size, Growth and Major Suppliers' Sales
and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott

- Affymetrix
- Applera
- Beckman Coulter
- Becton Dickinson
- Binding Site
- Biomerica
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Biosite
- Biotest
- Caliper Technologies
- Cepheid
- Chemicon
- Daiichi
- DiaSorin
- Diagast
- Diamedix
- Digene
- Eiken
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- Hemagen
- Immunetics
- Innogenetics
- Inverness
- JandJ
- Meridian
- Nanogen
- Nissui
- Olympus
- Provalis
- Roche
- Saliva Diagnostic
- SeraCare
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Tosho
- Trinity Biotech
- Tropix

- Wampole Labs
- Zenith
- Zeus
INFLUENZA DIAGNOSTICS MARKET: US, EUROPE, JAPAN
Test Volume, Sales Forecasts and Supplier Shares by Country


List of Tables
Major Companies Developing or Marketing Influenza
Tests
France
Influenza Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Influenza Testing Market Diagnostics Sales by Major
Supplier
Germany
Influenza Test Volume and Diagnostics Sales Forecast by Market
Segment
Germany
Influenza Testing Market Diagnostics Sales by Major
Supplier
Italy
Influenza Test Volume and Diagnostics Sales Forecast by Market
Segment
Italy
Influenza Testing Market Diagnostics Sales by Major
Supplier
Japan
Influenza Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
Influenza Testing Market Diagnostics Sales by Major
Supplier
Spain
Influenza Test Volume and Diagnostics Sales Forecast by Market
Segment

Spain
Influenza Testing Market Diagnostics Sales by Major
Supplier
U.K.
Influenza Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Influenza Testing Market Diagnostics Sales by Major
Supplier
U.S.A.
Influenza Test Volume and Diagnostics Sales Forecast by
Market Segment
U.S.A.
Influenza Testing Market Diagnostics Sales by Major
Supplier

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.